4.8 Article

Direct Carbon Isotope Exchange of Pharmaceuticals via Reversible Decyanation

期刊

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
卷 143, 期 15, 页码 5659-5665

出版社

AMER CHEMICAL SOC
DOI: 10.1021/jacs.1c01923

关键词

-

资金

  1. CEA
  2. European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant [675071]
  3. European Research Council [ERC-2019-COG -864576]
  4. FET-OPEN [862179]
  5. ANRT grant [CIFRE 2019/0914]
  6. Sanofi

向作者/读者索取更多资源

The use of carbon-14 allows for tracking of organic molecules and provides important knowledge on their fate. A new transition-metal-catalyzed procedure enables carbon isotope exchange on aromatic nitriles, reducing synthetic costs and limiting radioactive waste generation. This procedure will facilitate the labeling of nitrile-containing drugs and accelerate C-14-based ADME studies supporting drug development.
The incorporation of carbon-14 allows tracking of organic molecules and provides vital knowledge on their fate. This information is critical in pharmaceutical development, crop science, and human food safety evaluation. Herein, a transition-metal-catalyzed procedure enabling carbon isotope exchange on aromatic nitriles is described. By utilizing the radiolabeled precursor Zn([C-14]CN)(2), this protocol allows the insertion of the desired carbon tag without the need for structural modifications, in a single step. By reducing synthetic costs and limiting the generation of radioactive waste, this procedure will facilitate the labeling of nitrile containing drugs and accelerate C-14-based ADME studies supporting drug development.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据